ASCO Lung Cancer Highlights, Part 3: Immunotherapy for Stage III NSCLC (audio)
- Author
- cancerGRACE - H. Jack West, MD
- Published
- Tue 13 Aug 2013
- Episode Link
- http://cancergrace.libsyn.com/asco-lung-cancer-highlights-part-3-immunotherapy-for-stage-iii-nsclc-audio
Dr. David Gerber, University of Texas-Southwestern, reviews results of the START trial of tecemotide immunotherapy for stage III unresectable NSCLC.
